查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1655473

纖維蛋白膠的全球市場

Fibrin Sealants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 92 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球纖維蛋白膠市場規模將達到 16 億美元

2024 年全球纖維蛋白膠市場規模估計為 11 億美元，預計 2030 年將達到 16 億美元，2024 年至 2030 年的複合年成長率為 6.1%。纖維蛋白膠液是報告中分析的細分市場之一，預計複合年成長率為 6.4%，到分析期結束時將達到 12 億美元。在分析期內，纖維蛋白膠貼片部分預計將以 5.4% 的複合年成長率成長。

美國市場規模估計為 2.931 億美元，中國市場預期複合年成長率為 9.1%

預計 2024 年美國纖維蛋白膠市值將達 2.931 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 3.641 億美元，2024-2030 年分析期間的複合年成長率為 9.1%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 3.3% 和 5.9%。在歐洲，德國的複合年成長率預計為 3.7%。

全球纖維蛋白膠市場-主要趨勢與促進因素摘要

什麼是纖維蛋白膠？

纖維蛋白膠是一種生物黏合劑，用於各種醫療應用，促進創傷治療和組織修復。此密封劑由纖維蛋白原和凝血酶組成，模擬血液凝固過程的最後步驟，促進纖維蛋白凝塊的形成，有效密封傷口並促進止血。纖維蛋白膠廣泛應用於各種外科手術，包括一般外科手術、整形外科手術、神經外科手術和心血管外科手術。它能夠黏附於組織表面、減少出血並促進癒合，使其成為外科醫生和醫療保健專業人員的寶貴工具。

纖維蛋白膠在醫學領域的重要性不僅在於其黏合性能。纖維蛋白膠提供了一種微創解決方案來控制出血並促進組織癒合，減少了某些手術中對傳統縫線和釘書釘的需求。此外，纖維蛋白膠可以將抗生素和生長因子等治療劑直接輸送到傷口部位，進一步增強其效能。隨著對先進傷口護理和手術解決方案的需求不斷成長，纖維蛋白膠在改善患者預後和手術效率方面的作用越來越受到認可。

纖維蛋白膠的主要應用和醫療保健需求是什麼？

纖維蛋白膠廣泛應用於各種醫療領域，滿足醫療專業人員和患者的需求。在一般外科手術中，纖維蛋白膠通常用於控制肝切除術、胃切除術和結直腸切除術等手術期間的出血。可以快速止血，減少失血，降低併發症的風險，最終改善手術效果。在這些應用中使用纖維蛋白膠也有助於延長恢復時間並最大限度地減少術後疼痛，使患者和醫療機構都受益。

在整形外科手術中，纖維蛋白膠用於支持組織癒合並降低關節關節重建、韌帶修復和骨折融合術等手術後併發症的風險。纖維蛋白膠可促進組織黏合並改善癒合過程，有助於患者更快康復並改善功能結果。隨著外科醫生尋求有效的解決方案來最佳化手術結果，其在肌肉骨骼損傷管理中的應用變得越來越普遍。

神經外科是纖維蛋白膠越來越受歡迎的另一個領域。這些產品用於控制顱腦和脊椎手術期間的出血，因為控制出血至關重要。纖維蛋白膠的生物相容性和黏合特性使其非常適合在精細的手術環境中使用，可有效控制出血而不損害周圍組織。隨著神經外科技術的進步，纖維蛋白膠的採用預計會增加。

纖維蛋白膠也用於心血管外科手術，特別是心臟繞道手術和瓣膜置換術。纖維蛋白膠可在傳統縫合困難的部位提供有效止血，提高手術精確度並降低術後出血風險。微創心血管手術的需求不斷成長，進一步增加了對有效促進傷口縫合和癒合的纖維蛋白膠創新解決方案的需求。

此外，人們正在研究纖維蛋白膠在傷口護理和組織工程的新應用。纖維蛋白膠因其在慢性傷口管理中的應用而受到關注，因為它們可以透過提供對組織再生的支持環境來促進難以治療的傷口的癒合。隨著研究的不斷深入，新的應用將會被發現，擴大纖維蛋白膠在醫療保健產業的潛力，以滿足更廣泛的醫療需求。

科技進步如何影響纖維蛋白膠市場？

由於產品配方的改進、應用技術的改進和臨床應用的擴大，技術進步正在對纖維蛋白膠市場產生重大影響。一個顯著的發展是纖維蛋白膠配方的創新，旨在提高性能和易用性。製造商致力於製造具有最佳化黏度和流動特性的纖維蛋白膠，以便更容易應用並提高對組織表面的黏附性。這些進步使得外科醫生更容易使用纖維蛋白膠，並使其在各種外科手術中得到應用。

此外，對新輸送系統的研究正在擴大纖維蛋白膠的潛在應用。施用器和其他先進輸送方法的發展使得能夠精確、有針對性地應用纖維蛋白膠，從而提高其在各種臨床環境中的有效性。這些交付創新使醫療保健提供者能夠將纖維蛋白膠用於更廣泛的程序，從而確保最佳的性能和結果。

將生物相容性和生物活性成分整合到纖維蛋白膠配方中是影響市場的另一個趨勢。製造商正在探索將生長因子、抗菌劑和其他治療添加劑加入纖維蛋白膠中，以增強其癒合性能。這些進展旨在透過促進組織再生和降低感染風險來改善患者的治療效果。隨著這些增強功能的好處變得越來越明顯，對多功能纖維蛋白膠的需求預計會增加。

此外，微創手術技術的興起正在影響纖維蛋白膠市場。隨著外科醫生採用更多微創手術，對有效的傷口縫合解決方案來支持這些手術的需求也日益增加。纖維蛋白膠是微創手術的首選，因為它們提供了一種無需使用傳統縫合線即可促進止血和癒合的合適選擇。

纖維蛋白膠市場也受到以病人安全和法規遵循為重點的創新的推動。製造商投資研究和測試以確保其產品符合最高的安全性和有效性標準。專注於開發具有明確臨床療效和安全性的纖維蛋白膠對於獲得醫療保健提供者和監管機構的認可至關重要。對品質和安全的承諾有望提高纖維蛋白膠在醫學界的聲譽。

推動纖維蛋白膠市場成長的因素是什麼？

纖維蛋白膠市場的成長受到多種關鍵因素的推動，例如外科手術的增加、對先進創傷護理解決方案的需求不斷成長以及對減少術後併發症的關注。其中一個主要因素是全球外科手術數量的增加。隨著醫療保健產業的不斷擴大，對有效止血和傷口縫合解決方案的需求日益增加。纖維蛋白膠是控制出血和促進癒合的有效選擇，已成為各種外科專業的必需品。

對先進傷口護理解決方案的需求不斷成長也是推動市場成長的關鍵因素。隨著慢性傷口、壓瘡和手術部位感染的增加，醫療保健提供者正在尋求創新方法來加速創傷治療並減少併發症。纖維蛋白膠具有支持組織修復和降低感染風險的能力，在傷口處理中越來越受歡迎。對病人安全和改善臨床結果的關注推動了對有效創傷護理產品的需求增加。

此外，越來越重視減少術後併發症和延長恢復時間也對纖維蛋白膠市場產生了影響。醫療保健提供者認知到使用纖維蛋白膠的好處：它們可以減少出血，促進癒合，並最大限度地減少額外干預的需要。由於醫院和外科中心優先考慮患者的治療結果和效率，預計纖維蛋白膠在外科實踐中的應用將會增加。

此外，手術技術和技術的進步促進了纖維蛋白膠被納入常規手術實踐中。隨著微創手術變得越來越普遍，對有效的傷口縫合解決方案的需求也日益增加，以適應這些技術。纖維蛋白膠提供了一種無需使用傳統縫合線即可促進止血和癒合的合適選擇，從而有助於其在各種外科專業中的廣泛應用。

最後，正在進行的研究和臨床研究調查纖維蛋白膠在各種應用中的功效，正在推動市場成長。隨著有關纖維蛋白膠在各種外科手術中的益處的新證據出現，醫療保健提供者可能會將這些產品納入他們的實踐中。越來越多的臨床資料支持使用纖維蛋白膠，纖維蛋白膠可能會增加其在醫學界的接受度和利用率。

總之，由於外科手術數量的增加、對先進創傷護理解決方案的需求不斷成長以及對減少術後併發症的關注，纖維蛋白膠市場預計將顯著成長。產品配方和交付方法的技術進步可能會進一步增加市場潛力。隨著醫療保健提供者繼續優先考慮患者安全和有效的傷口管理，預計未來幾年對纖維蛋白膠的需求將會成長。

部分

類型（液體、貼片）；應用（心血管外科、整形外科、一般外科、移植外科、其他）；最終用途（醫院、專科診所、其他最終用途）

受訪公司範例（值得關注的36家公司）

  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP17257

Global Fibrin Sealants Market to Reach US$1.6 Billion by 2030

The global market for Fibrin Sealants estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Fibrin Sealant Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Fibrin Sealant Patches segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$293.1 Million While China is Forecast to Grow at 9.1% CAGR

The Fibrin Sealants market in the U.S. is estimated at US$293.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$364.1 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Fibrin Sealants Market – Key Trends & Drivers Summarized

What Are Fibrin Sealants, And Why Are They Essential in Medical Applications?

Fibrin sealants are a type of biological adhesive used in various medical applications to promote wound healing and tissue repair. Composed of fibrinogen and thrombin, these sealants mimic the final stages of the blood coagulation process, facilitating the formation of a fibrin clot that effectively seals wounds and enhances hemostasis. Fibrin sealants are used in a wide range of surgical procedures, including general surgery, orthopedics, neurosurgery, and cardiovascular surgery. Their ability to adhere to tissue surfaces, control bleeding, and accelerate healing makes them a valuable tool for surgeons and healthcare professionals.

The significance of fibrin sealants in medical practice extends beyond their adhesive properties. They provide a minimally invasive solution for managing bleeding and promoting tissue healing, reducing the need for traditional sutures and staples in certain procedures. Additionally, fibrin sealants can deliver therapeutic agents, such as antibiotics or growth factors, directly to the wound site, further enhancing their effectiveness. As the demand for advanced wound care and surgical solutions continues to rise, the role of fibrin sealants in improving patient outcomes and surgical efficiency is increasingly recognized.

What Are the Main Applications of Fibrin Sealants, And How Do They Cater to Healthcare Needs?

Fibrin sealants have a wide range of applications across various medical fields, catering to the specific needs of healthcare providers and patients. In general surgery, fibrin sealants are commonly used to control bleeding during procedures such as liver resections, gastric surgeries, and colorectal surgeries. Their ability to provide rapid hemostasis helps reduce blood loss and the risk of complications, ultimately improving surgical outcomes. The use of fibrin sealants in these applications also enhances recovery times and minimizes postoperative pain, benefiting both patients and healthcare facilities.

In orthopedic surgery, fibrin sealants are employed to support tissue healing and reduce the risk of complications following procedures such as joint replacements, ligament repairs, and fracture fixations. By promoting the adhesion of tissues and enhancing the healing process, fibrin sealants contribute to faster recovery and improved functional outcomes for patients. Their application in managing musculoskeletal injuries is becoming increasingly common as surgeons seek effective solutions to optimize surgical results.

Neurosurgery is another area where fibrin sealants are gaining traction. They are used to manage bleeding during cranial and spinal procedures, where controlling hemorrhage is critical. The biocompatibility and adhesive properties of fibrin sealants make them ideal for use in delicate surgical environments, ensuring that bleeding is effectively managed without compromising surrounding tissues. As advancements in neurosurgical techniques continue, the adoption of fibrin sealants is expected to increase.

Fibrin sealants are also used in cardiovascular surgery, particularly in procedures involving cardiac bypass and valve replacement. They provide effective hemostasis in areas where traditional sutures may be challenging to apply, enhancing surgical precision and reducing the risk of postoperative bleeding. The growing demand for minimally invasive cardiovascular procedures is further driving the need for innovative solutions like fibrin sealants that promote effective wound closure and healing.

Furthermore, fibrin sealants are being explored in emerging applications, such as wound care and tissue engineering. Their use in chronic wound management is gaining attention, as they can enhance healing in difficult-to-treat wounds by providing a supportive environment for tissue regeneration. As research continues to uncover new applications, the potential for fibrin sealants in the healthcare industry will likely expand, catering to a broader range of medical needs.

How Are Technological Advancements Impacting the Fibrin Sealants Market?

Technological advancements are significantly influencing the fibrin sealants market by improving product formulations, enhancing application techniques, and expanding their clinical use. One notable development is the innovation in fibrin sealant formulations, which aim to enhance their performance and usability. Manufacturers are focusing on creating fibrin sealants with optimized viscosity and flow characteristics, enabling easier application and improved adhesion to tissue surfaces. These advancements make fibrin sealants more user-friendly for surgeons, contributing to their growing adoption in various surgical procedures.

Additionally, research into novel delivery systems is expanding the potential applications of fibrin sealants. The development of spray applicators and other advanced delivery methods allows for precise and targeted application of fibrin sealants, improving their effectiveness in diverse clinical settings. These delivery innovations enable healthcare providers to use fibrin sealants in a broader range of procedures, ensuring optimal performance and outcomes.

The integration of biocompatible and bioactive components into fibrin sealant formulations is another trend impacting the market. Manufacturers are exploring the incorporation of growth factors, antimicrobial agents, and other therapeutic additives into fibrin sealants to enhance their healing properties. These advancements are aimed at improving patient outcomes by promoting tissue regeneration and reducing the risk of infection. As research continues to uncover the benefits of these enhancements, the demand for multifunctional fibrin sealants is expected to grow.

Moreover, the rise of minimally invasive surgical techniques is influencing the fibrin sealants market. As surgeons increasingly adopt less invasive approaches to procedures, the need for effective wound closure solutions that align with these techniques is rising. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, making them a preferred choice in minimally invasive surgeries.

The emphasis on patient safety and regulatory compliance is also driving innovation in the fibrin sealants market. Manufacturers are investing in research and testing to ensure that their products meet the highest safety and efficacy standards. The focus on developing fibrin sealants with proven clinical benefits and safety profiles is essential for gaining acceptance among healthcare providers and regulatory bodies. This commitment to quality and safety is expected to enhance the reputation of fibrin sealants in the medical community.

What Is Driving the Growth in the Fibrin Sealants Market?

The growth in the fibrin sealants market is driven by several key factors, including increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. One of the primary drivers is the growing number of surgical procedures performed globally. As the healthcare industry continues to expand, the demand for effective hemostatic agents and wound closure solutions is increasing. Fibrin sealants provide an effective option for controlling bleeding and promoting healing, making them essential in various surgical specialties.

The rising demand for advanced wound care solutions is another significant factor contributing to market growth. With an increasing prevalence of chronic wounds, pressure ulcers, and surgical site infections, healthcare providers are seeking innovative approaches to enhance wound healing and reduce complications. Fibrin sealants, with their ability to support tissue repair and reduce infection risks, are becoming increasingly popular in wound management. The ongoing emphasis on patient safety and improved clinical outcomes is further driving the demand for effective wound care products.

Additionally, the focus on minimizing postoperative complications and enhancing recovery times is influencing the fibrin sealants market. Healthcare providers are recognizing the benefits of using fibrin sealants in reducing bleeding, promoting healing, and minimizing the need for additional interventions. As hospitals and surgical centers prioritize patient outcomes and efficiency, the adoption of fibrin sealants in surgical practice is expected to grow.

Moreover, advancements in surgical techniques and technology are facilitating the integration of fibrin sealants into routine surgical practice. As minimally invasive procedures gain popularity, the need for effective wound closure solutions that align with these techniques becomes increasingly important. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, contributing to their growing use in various surgical specialties.

Finally, ongoing research and clinical studies investigating the efficacy of fibrin sealants in different applications are driving market growth. As new evidence emerges regarding the benefits of fibrin sealants in various surgical procedures, healthcare providers are likely to incorporate these products into their practice. The expanding body of clinical data supporting the use of fibrin sealants will enhance their acceptance and utilization in the medical community.

In conclusion, the fibrin sealants market is poised for significant growth driven by increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. Technological advancements in product formulations and delivery methods will further enhance the market's potential. As healthcare providers continue to prioritize patient safety and effective wound management, the demand for fibrin sealants is expected to flourish in the coming years.

SCOPE OF STUDY:

The report analyzes the Fibrin Sealants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Liquid, Patches); Application (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery, Other Applications); End-Use (Hospitals, Specialty Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Fibrin Sealants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Adoption of Fibrin Sealants in Hemostasis and Wound Healing Expands Addressable Market
    • Surge in Demand for Fibrin Sealants in Minimally Invasive Surgeries Fuels Market Growth
    • Growing Focus on Fibrin Sealants for Reducing Blood Loss and Postoperative Complications Strengthens Business Case
    • Surge in Adoption of Fibrin Sealants in Orthopedic and Trauma Surgeries Expands Market Opportunities
    • Growing Demand for Fibrin Sealants in Dental and Maxillofacial Surgeries Expands Addressable Market
    • Surge in Adoption of Fibrin Sealants in Plastic and Reconstructive Surgeries Expands Market Opportunities
    • Technological Advancements in Fibrin Sealants for Enhanced Biocompatibility Propel Market Growth
    • Growing Use of Fibrin Sealants in Neurosurgery and Spinal Procedures Strengthens Business Case
    • Rising Adoption of Fibrin Sealants in Emerging Markets with Expanding Healthcare Infrastructure Sets the Stage for Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Cardiovascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Transplant Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Fibrin Sealants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION